| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SPNE | Common Stock | Disposed to Issuer | -131K | -100% | 0 | Jan 5, 2023 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SPNE | Restricted Stock Units | Disposed to Issuer | -13K | -100% | 0 | Jan 5, 2023 | Common Stock | 13K | Direct | F2, F3, F4 | |||
| transaction | SPNE | Restricted Stock Units | Disposed to Issuer | -34K | -100% | 0 | Jan 5, 2023 | Common Stock | 34K | $0.00 | Direct | F2, F5, F6 | ||
| transaction | SPNE | Employee Stock Option (Right to Buy) | Disposed to Issuer | -60K | -100% | 0 | Jan 5, 2023 | Common Stock | 60K | $15.68 | Direct | F7, F8 | ||
| transaction | SPNE | Employee Stock Option (Right to Buy) | Disposed to Issuer | -64.6K | -100% | 0 | Jan 5, 2023 | Common Stock | 64.6K | $14.19 | Direct | F9, F10 | ||
| transaction | SPNE | Employee Stock Option (Right to Buy) | Disposed to Issuer | -35.6K | -100% | 0 | Jan 5, 2023 | Common Stock | 35.6K | $18.24 | Direct | F11, F12 | ||
| transaction | SPNE | Employee Stock Option (Right to Buy) | Disposed to Issuer | -27.9K | -100% | 0 | Jan 5, 2023 | Common Stock | 27.9K | $12.01 | Direct | F13, F14 | ||
| transaction | SPNE | Employee Stock Option (Right to Buy) | Disposed to Issuer | -6.09K | -100% | 0 | Jan 5, 2023 | Common Stock | 6.09K | $9.93 | Direct | F15, F16 | ||
| transaction | SPNE | Employee Stock Option (Right to Buy) | Disposed to Issuer | -16.2K | -100% | 0 | Jan 5, 2023 | Common Stock | 16.2K | $16.86 | Direct | F17, F18 | ||
| transaction | SPNE | Employee Stock Option (Right to Buy) | Disposed to Issuer | -21.2K | -100% | 0 | Jan 5, 2023 | Common Stock | 21.2K | $15.00 | Direct | F19, F20 |
Tyler Lipschultz is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 54,653 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. |
| F3 | The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. |
| F4 | These restricted stock units were assumed by Orthofix in the merger and replaced by 5,399 Orthofix restricted stock units. |
| F5 | The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. |
| F6 | These restricted stock units were assumed by Orthofix in the merger and replaced by 14,144 Orthofix restricted stock units. |
| F7 | The option vests as to 25% of the underlying shares on August 1, 2016 and the remaining 75% vests in twelve substantially equal quarterly installments thereafter. |
| F8 | This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,978 shares of Orthofix at a price of $37.67 per share. |
| F9 | The option vests as to 12.5% of the underlying shares on August 1, 2016, 6.25% on September 30, 2016 and the remaining 81.25% vests in thirteen substantially equal quarterly installments thereafter. |
| F10 | This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share. |
| F11 | The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| F12 | This option was assumed by Orthofix in the merger and replaced with an option to purchase 14,835 shares of Orthofix at a price of $43.82 per share. |
| F13 | The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| F14 | This option was assumed by Orthofix in the merger and replaced with an option to purchase 11,603 shares of Orthofix at a price of $28.85 per share. |
| F15 | The option fully vested and became exercisable on June 21, 2020. |
| F16 | This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,534 shares of Orthofix at a price of $23.86 per share. |
| F17 | The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| F18 | This option was assumed by Orthofix in the merger and replaced with an option to purchase 6,742 shares of Orthofix at a price of $40.50 per share. |
| F19 | The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| F20 | This option was assumed by Orthofix in the merger and replaced with an option to purchase 8,840 shares of Orthofix at a price of $36.04 per share. |